Steven Oh PhD U.S. FDA

Dr. Steven Oh is Deputy Office Director, Office of Cellular Therapy and Human Tissue in CBER, FDA. He oversees product quality review and policy development programs focused on cell therapy, tissue-engineered products, and medical devices including combination products. He also heads the bioinformatics regulatory group. Dr. Oh has been with CBER for over 16 years and served in the past as Director and Deputy Director of Division of Cellular and Gene Therapies, Chief of Cell Therapy Branch, and Combination Product Team Leader. His scientific and regulatory interests include emerging novel technologies in regenerative medicine therapies and individualized medicine, standards development and use, and global regulatory convergence in advanced therapy products. Before joining FDA in 2007, Dr. Oh served on the faculty of Tufts University School of Medicine. He was trained as a cell biologist and biochemist at the University of Michigan, Johns Hopkins University School of Medicine, and Massachusetts Institute of Technology.